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Abstract 
Malignant transformation of a mature cystic 
teratoma is extremely rare, occurring in 0.17-2% 
of cases.1 The most common malignant 
degeneration is squamous cell carcinoma (SCC) 
arising from the ectoderm.  Approximately half of 
all cases of SCC of the ovary are confined to the 
ovary at time diagnosis.1,2 Secondary to its 
absolute rarity and the relative infrequency of 
cases with metastatic spread the optimal 
treatment of advanced stage disease is 
unknown.  Outcomes for locally advanced and 
widespread disease have historically been very 
poor.  Ford and Timmons recently reported on a 
patient with stage IIC SCC arising in a mature 
cystic teratoma treated with multimodal therapy 
who has been free of disease for more than five 
years.3 Herein we report on a woman with stage 
IIIC SCC arising within a mature cystic teratoma 
treated with directed chemoradiation who 
subsequently developed metastatic SCC to the 
colon. 
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Introduction 
Malignant  transformation of a mature 
cystic teratoma is extremely rare, 
occurring in 0.17-2% of cases.1 The 
most common malignant degeneration 
is squamous cell carcinoma (SCC) 
arising from the ectoderm. 
Approximately half of all cases of SCC 
of the ovary are confined to the ovary at 
time diagnosis.1,2 Secondary to its 
absolute rarity and the relative 
infrequency of cases with metastatic 
spread the optimal treatment of 
advanced stage disease is unknown. 
Outcomes for locally advanced and 
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widespread disease have historically 
been very poor. Ford and Timmons 
recently reported on a patient with stage 
IIC SCC arising in a mature cystic 
teratoma treated with multimodal 
therapy who has been free of disease 
for more than five years.3 Herein we 
report on a woman with stage IIIC SCC 
arising within a mature cystic teratoma 
treated with directed chemoradiation 
who subsequently developed metastatic 
SCC to the colon. 
 
Case 
A 43 year old woman originally 
presented to the Emergency 
Department with complaint of right lower 
quadrant pain. On review of systems 
she also admitted to urinary symptoms, 
including frequency and nocturia. Her 
past medical history was significant only 
for anxiety. Past surgical history was 
significant for a cesarean section and 
laparoscopic tubal ligation in 2004. Pap 
smears at our facility dating back to 
2000 were noted to be within normal 
limits.  
 
Figure 1.  Medium power of ovarian squamous carcinoma with embedded hair 
shaft material (inset, high power) and foreign body giant cell reaction to hair 
material.  Hematoxylin and eosin stain.   
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Pertinent findings on physical exam 
included right adnexal fullness and 
tenderness. A transvaginal ultrasound 
showed a heterogenous complex right 
ovarian mass measuring 17 x 14 x 8 cm. 
She was consented for surgery. At time 
of laparotomy, the right ovary appeared 
grossly abnormal with a purplish-gray 
color with cystic areas that appeared to 
contain congested blood. The ovary was 
densely adherent to the right pelvic 
sidewall. A right salpingo-oophorectomy 
was performed and the specimen was 
sent for pathologic examination. 
Exploration of the pelvis and abdomen 
revealed a normal left fallopian tube and 
ovary. There was a dense whitish 
plaque covering the bladder peritoneum, 
uterosacral ligaments and cul-de-sac. 
There were also a few scattered 
peritoneal implants, appendiceal 
implants, but no grossly evident omental 
tumor.  
Frozen section of the right ovary and a 
peritoneal implant demonstrated 
carcinoma with squamous 
differentiation. She underwent a 
debulking and staging procedure 
including a modified radical 
hysterectomy, left salpingo-
oophorectomy, omentectomy, 
appendectomy, pelvic and para-aortic 
lymphadenectomy and peritoneal 
biopsies. Peritoneal implants were 
fulgurated with the argon beam 
coagulator. She was optimally debulked. 
Her post-operative course was 
uneventful and she was discharged 
home on post-operative day three.   
Pathologic examination of the right 
ovary showed complete replacement by 
a 17 x 14x 8 cm solid partially necrotic 
mass consisting of squamous cell 
carcinoma. The presence of hair shaft 
fragments surrounded by tumor 
suggested that the carcinoma arose as 
a result of malignant transformation of a 
mature cystic teratoma (Figure 1). 
 
Figure 2.  Colonoscopy demonstrated a fungating lesion with central ulceration 
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No other mature or immature teratoid 
elements were identified. Metastatic 
squamous carcinoma also involved the 
uterine serosa, parametrium, bilateral 
lymph nodes and omentum. She 
received three cycles of adjuvant 
chemotherapy with cisplatin and 
paclitaxel followed by radiation therapy 
to the pelvis (4860 cGy total dose given 
in 26 fractions of 180 cGy/fraction) 
administered with weekly cisplatin. She 
then received an additional three cycles 
of cisplatin and paclitaxel. An MRI 
performed at the completion of therapy 
did not show any evidence of persistent 
or metastatic disease. Several months 
after the completion of chemotherapy, 
she complained of hematochezia. Digital 
rectal exam revealed a palpable mass. 
A colonoscopy was performed. A 
fungating lesion with central ulceration 
was noted extending from 5 to10 cm 
from the anal verge (Figure 2); multiple 
biopsies were obtained. 
 
Figure 3. Rectum 5 cm. from anal verge, biopsy. 200x. The squamous cell 
carcinoma is characterized by keratin pearl formation (blue arrow) and 
intercellular bridges (green arrow).   
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The remainder of the colonoscopy, 
including terminal ileal intubation, was 
within normal limits. Biopsies of the 
rectal mass showed colonic mucosa 
infiltrated by a moderately differentiated 
squamous cell carcinoma (Figure 3). 
The tumor involved the submucosa and 
mucosa, with no in situ component, 
compatible with metastasis from another 
site. The tumor was histologically 
identical to the squamous cell 
carcinoma from her right ovary. 
Discussion 
Malignant transformation of a mature 
cystic teratoma is a rare event. We 
describe a case of SCC originating from 
such a degeneration. This case is also 
unique in that the tumor metastasized to 
the colon four months after receiving 
aggressive surgery, chemo- and 
radiation therapies. Metastatic SCC to 
the colon has been described in the 
literature but, typically, these tumors 
originate from a pulmonary tumor.4,5 
Although metastasis to the rectum from 
ovarian squamous cell carcinoma has 
been described,6,7 to our knowledge, 
this is the first case of recurrent SCC to 
the colon arising from the malignant 
degeneration of a mature cystic 
teratoma. 
Our management in this case was 
cognizant of the historically dismal 
outcomes for patients with advanced 
stage SCC of the ovary, prompting the 
initial optimal cytoreduction and 
complete staging followed by multimodal 
aggressive therapy, consisting of 
combination platinum-based 
chemotherapy and external beam 
radiation with cisplatin sensitization. 
Secondary to the rarity of this specific 
entity, the optimal adjuvant therapy is 
unknown with data limited to case 
reports and small case series with 
varied chemotherapies, radiation or a 
combination thereof. Our multimodality 
approach was based on a review of the 
literature supporting combination 
adjuvant therapy squamous cell 
carcinomas arising in an ovarian 
teratoma .2,3  
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